Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · Real-Time Price · USD
62.90
-0.41 (-0.65%)
At close: Aug 1, 2025, 4:00 PM
60.01
-2.89 (-4.59%)
After-hours: Aug 1, 2025, 6:13 PM EDT
Cidara Therapeutics Market Cap
Cidara Therapeutics has a market cap or net worth of $1.39 billion as of August 1, 2025. Its market cap has increased by 2,257.96% in one year.
Market Cap
1.39B
Enterprise Value
1.23B
1-Year Change
2,257.96%
Ranking
Category
Stock Price
$62.90
Market Cap Chart
Since April 15, 2015, Cidara Therapeutics's market cap has increased from $203.10M to $1.39B, an increase of 584.98%. That is a compound annual growth rate of 20.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 821.10M | 333.53% |
| Dec 31, 2024 | 189.40M | 163.79% |
| Dec 29, 2023 | 71.80M | 32.47% |
| Dec 30, 2022 | 54.20M | -36.01% |
| Dec 31, 2021 | 84.70M | -3.64% |
| Dec 31, 2020 | 87.90M | -30.73% |
| Dec 31, 2019 | 126.90M | 94.63% |
| Dec 31, 2018 | 65.20M | -52.62% |
| Dec 29, 2017 | 137.60M | -20.65% |
| Dec 30, 2016 | 173.40M | -26.34% |
| Dec 31, 2015 | 235.40M | 15.90% |
| Apr 15, 2015 | 203.10M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.46B |
| Johnson & Johnson | 405.44B |
| AbbVie | 336.02B |
| UnitedHealth Group | 239.21B |
| AstraZeneca | 230.79B |
| Novartis AG | 227.02B |
| Abbott Laboratories | 224.72B |
| Novo Nordisk | 221.96B |